| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/14/2011 | US20110172288 Compositions and Methods for the Identification, Assessment, Prevention and Therapy of Thymic Lymphoma or Hamartomatous Tumours |
| 07/14/2011 | US20110172286 Cd44 splice variants in neurodegenerative diseases |
| 07/14/2011 | US20110172170 Interferon-like protein zcyto21 |
| 07/14/2011 | US20110172114 Compositions and methods for the treatment of immune related diseases |
| 07/14/2011 | US20110171720 Single-domain brain-targeting antibody fragments derived from llama antibodies |
| 07/14/2011 | US20110171715 Biocompatible polymer and magnetic nanoparticle with biocompatibility |
| 07/14/2011 | US20110171688 Method of providing immunoglobulin secreting b lymphocytes and human antibodies |
| 07/14/2011 | US20110171678 Modified carbocyanine dyes and their conjugates |
| 07/14/2011 | US20110171627 Zcytor19 heterodimeric cytokine receptor polynucleotides, polypeptides, antibodies and methods |
| 07/14/2011 | US20110171291 Pathologically-activated therapeutics |
| 07/14/2011 | US20110171253 Novel astrovirus |
| 07/14/2011 | US20110171238 Novel stra6 polypeptides |
| 07/14/2011 | US20110171237 Phep, an amino acid permease of staphylococcus aureus |
| 07/14/2011 | US20110171236 Anthrax and small pox replikins and methods of use |
| 07/14/2011 | US20110171235 Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins |
| 07/14/2011 | US20110171234 Vaccine |
| 07/14/2011 | US20110171233 Antibodies Against Human Cytomegalovirus (HCMV) |
| 07/14/2011 | US20110171231 ANTI-PlGF ANTIBODIES AND METHODS USING SAME |
| 07/14/2011 | US20110171230 Method of Identifying Agents that Promote Axonal Development |
| 07/14/2011 | US20110171226 Novel Subtype of Closteridium Botulinum Neurotoxin Type A and Uses Thereof |
| 07/14/2011 | US20110171225 Novel Plasmodium Falciparum Gene Encoding Signal Peptide Peptidase and Method of Using Inhibitors Thereof for Inhibiting Malarial Infection |
| 07/14/2011 | US20110171223 Anti-peptide antibodies that cross react with protective antigen of bacillus anthracis and uses thereof |
| 07/14/2011 | US20110171222 Anti-her3 antibodies and uses thereof |
| 07/14/2011 | US20110171221 Compositions and methods for the treatment of a neoplasia |
| 07/14/2011 | US20110171220 Pd-1 specific antibodies and uses thereof |
| 07/14/2011 | US20110171216 Monoclonal antibodies specific for pancreatic neoplasia cells |
| 07/14/2011 | US20110171215 Pd-1 specific antibodies and uses thereof |
| 07/14/2011 | US20110171210 Humanized monoclonal antibodies and methods of use |
| 07/14/2011 | US20110171208 Cd37 immunotherapeutic and combination with bifunctional chemotherapeutic thereof |
| 07/14/2011 | US20110171205 Novel 15571, 2465, 14266, 2882, 52871, 8203 and 16852 molecules and uses therefor |
| 07/14/2011 | US20110171204 Antibodies to ntb-a |
| 07/14/2011 | US20110171173 Ifn-alpha/beta-independent mechanism of antiviral protection through a novel ligand-receptor pair: ifn- ligands engage a novel receptor ifn-rn (crf2-12) and il-10r2 (crf2-4) for signaling andinduction of biological activities |
| 07/14/2011 | US20110171127 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer |
| 07/14/2011 | US20110171125 ANTI-FcRH5 ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE |
| 07/14/2011 | US20110171123 In Vivo Biofilm Infection Diagnosis and Treatment |
| 07/14/2011 | CA2786692A1 Biomarkers of immunomodulatory effects in humans treated with anti-cd200 antibodies |
| 07/14/2011 | CA2786019A1 Plasma kallikrein binding proteins |
| 07/14/2011 | CA2785226A1 Photo-inactivated viruses and systems and methods of using the same |
| 07/14/2011 | CA2784137A1 Assay for jc virus antibodies |
| 07/14/2011 | CA2783846A1 Antibody formulation |
| 07/13/2011 | EP2343380A1 Immunoglobulin variable region cassette exchange |
| 07/13/2011 | EP2343321A1 Human antibodies specific for carcinoma |
| 07/13/2011 | EP2343320A1 GITR binding molecules and uses therefor |
| 07/13/2011 | EP2343319A1 Genetically modified food grade microorganism for treatment of inflammatory bowel disease |
| 07/13/2011 | EP2343318A2 Antibodies binding to a C-terminal fragment of Apolipoprotein E |
| 07/13/2011 | EP2343316A1 Ligand binding site of RAGE and uses thereof |
| 07/13/2011 | EP2343315A2 Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers |
| 07/13/2011 | EP2343313A1 Polypeptides from non-typeable haemophilus influenzae |
| 07/13/2011 | EP2343312A1 Genes of an otitis media isolate of nontypeable haemophilus influenzae |
| 07/13/2011 | EP2343086A2 Antibodies to CD40 |
| 07/13/2011 | EP2343085A2 Antibody against prostate stem cell antigen (PSCA) |
| 07/13/2011 | EP2342568A1 Cadherin-17 as diagnostic marker and therapeutic target for liver cancer |
| 07/13/2011 | EP2342350A1 Method for polyclonal immunoglobulin g production by human b cells |
| 07/13/2011 | EP2342318A1 High titer antibody production |
| 07/13/2011 | EP2342234A2 Monoclonal antibodies for treatment of cancer |
| 07/13/2011 | EP2342233A1 Anti cxcr4 antibodies and their use for the treatment of cancer |
| 07/13/2011 | EP2342232A2 Fibroblast growth factor receptor-3 (fgfr-3) inhibitors and methods of treatment |
| 07/13/2011 | EP2342231A1 Bispecific anti-egfr/anti-igf-1r antibodies |
| 07/13/2011 | EP2342230A1 Materials and methods for inhibiting cancer cell invasion related to fgfr4 |
| 07/13/2011 | EP2342229A1 Pd-1 specific antibodies and uses thereof |
| 07/13/2011 | EP2342228A1 Pd-1 specific antibodies and uses thereof |
| 07/13/2011 | EP2342227A1 Treatment of acute lymphoblastic leukemia |
| 07/13/2011 | EP2342226A2 Human anti-pd-1, pd-l1, and pd-l2 antibodies and uses therefor |
| 07/13/2011 | EP2342220A1 Methods and systems for predicting misfolded protein epitopes |
| 07/13/2011 | EP2341945A2 Methods and therapies for treating inflammatory conditions with exposed collagen |
| 07/13/2011 | EP2341940A1 The stabilisation of proteins |
| 07/13/2011 | EP2341939A2 Dendritic cell modulatory molecule |
| 07/13/2011 | EP2341937A1 Composition for treating disease |
| 07/13/2011 | EP2341936A1 METHODS FOR TREATING OR PREVENTING IL-1ß RELATED DISEASES |
| 07/13/2011 | EP2341935A1 Methods for improvement of beta cell function |
| 07/13/2011 | EP2341934A2 Methods to reduce b-helper t cells to treat autoimmune diseases |
| 07/13/2011 | EP2341933A1 Lipidated imidazoquinoline derivatives |
| 07/13/2011 | EP2341929A1 Compositions and methods related to bacterial eap, emp, and/or adsa proteins |
| 07/13/2011 | EP2143438B1 Compositions and methods for the diagnosis and treatment of tumors |
| 07/13/2011 | EP1828247B1 Binding molecules capable of neutralizing west nile virus and uses thereof |
| 07/13/2011 | EP1765398B1 Human antibodies interacting with hiv gp41 |
| 07/13/2011 | EP1633784B1 Ovr110 antibody compositions and methods of use |
| 07/13/2011 | EP1289553B1 Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 07/13/2011 | EP1190043B1 Glycoprotein vi and uses thereof |
| 07/13/2011 | CN102124344A Use of biomarkers for assessing treatment of gastrointestinal inflammatory disorders with beta7 integrin antagonists |
| 07/13/2011 | CN102124122A Methods of detecting cells with a disrupted cell membrane, cells infected with a pathogen, dying cells or dead cells |
| 07/13/2011 | CN102124105A Antibody capable of binding specifically to Abeta-oligomer, and use thereof |
| 07/13/2011 | CN102124030A Antibody against oxidized ldl/ss2gpi complex and use of the same |
| 07/13/2011 | CN102124029A Method of diagnosis of infection by mycobacteria and reagents therefor |
| 07/13/2011 | CN102124028A Monoclonal antibodies having homosubtype cross -neutralization properties against influenza a viruses subtype h1 |
| 07/13/2011 | CN102124027A Process for producing milk fractions rich in secretory immunoglobulins |
| 07/13/2011 | CN102123728A Compounds for treating amyloidoses |
| 07/13/2011 | CN102123727A Compounds for treating beta-amyloidoses |
| 07/13/2011 | CN102123726A Compounds for treating symptoms associated with parkinson's disease |
| 07/13/2011 | CN102123582A Antibody producing non-human mammals |
| 07/13/2011 | CN102120773A Dual specificity antibodies and methods of making and using |
| 07/13/2011 | CN102120772A Chimeric antibody and immunocyte |
| 07/13/2011 | CN102120771A Preparation method of rabbit monoclonal antibody for resisting Cry1c crystal protein |
| 07/13/2011 | CN102120770A Preparation method of rabbit monoclonal antibody for resisting Cry1Ac crystal protein |
| 07/13/2011 | CN102120769A Preparation method of rabbit monoclonal antibody for resisting beta-glucuronidase |
| 07/13/2011 | CN102120768A Method for producing curative canine parvovirus virus monoclonal antibody by using bioreactor |
| 07/13/2011 | CN102120762A Arabidopsis anthocyanin pap1 purified protein and preparation method and applications thereof |
| 07/13/2011 | CN101735987B Mouse monoclonal antibody cell strain for resisting amoxicillin and ampicillin |
| 07/12/2011 | US7977468 Chromosome 3p21.3 genes are tumor suppressors |
| 07/12/2011 | US7977465 Peptidyl prodrugs and linkers and stabilizers useful therefor |